Liu et al. have revealed that PD-L1 can have both a positive and negative effect on GBM patient survival depending on the glioma subclass, on expression levels of PD-L1 regulatory molecules, and most importantly on the cell type that expresses PD-L1 in the tumor microenvironment [101]. Here, CD274 is linked to glioblastoma.